Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open‑label randomised controlled trial Kaura et al.(2019) https://t.co/sIyKxiWIY0 Rate of PAF using Zio was 16.2% compared to 2.1% with holter, and Zio is likely to be more cost effective
288 followers
288 followers
Randomised multi-centre study demonstrates Zio® monitor’s superiority in detecting paroxysmal atrial fibrillation (PAF) immediately post cryptogenic stroke and transient ischaemic attack (TIA) https://t.co/AXFMXHq5gk https://t.co/Nb3VBEXKqf
288 followers
A pivotal randomised study called EPACS in 2019 by Kings College London NHS Trust looked into stroke prevention using the Zio service, and found that; 16.3% of PAF was detected using Zio compared with only 2.1% of holter patients: https://t.co/AXFMXHq5gk
1,119 followers
@iRhythmTech @DailyMailUK Great to see the results of our @KingsCollegeNHS EPACS trial reaching a wider audience. https://t.co/lSV5oOkwzg